Mymetics Corp (MYMX)

[Harry Wickey]

Corpus,
Thanks for your input but interpreting the information to say that the pre-clinical studies are successful could be a reach (I hope not). The article did not mention any results on the current studies. It might be in the translation or English being a second language. The PATH-MVI study is due in early 2016, which is now and HIV was due in Late 2015 which is late. I truly hope you are right and these studies have been successful, (meaning the results are very good). But throwing them in with past results seems strange to me.

This paragraph is awful and I will contact company as to what it really means.

"Mymetics' virosome based vaccine candidates for HIV and Malaria have finished successfully Phase I clinical trials and in new pre-clinical studies which are financed through non-dilutive funding by the Bill & Melinda Gates Foundation and PATH-MVI respectively. In addition, Mymetics has an intra-nasal influenza virosome vaccine that has successfully completed a Phase I trial.